Cohance Lifesciences Limited, formerly Suven Pharmaceuticals Limited, is an India-based company focused on global contract development and manufacturing organization (CDMO) platform. The Company specializes in providing end-to-end solutions across the molecule's lifecycle from early-stage development to large-scale commercialization- with a marquee customer base across pharmaceuticals and specialty chemicals. It offers a platform for the lifecycle of small molecule active pharmaceutical ingredient (API) development and manufacturing. Its Integrated Small Molecule Solutions offers good manufacturing practice (GMP)-grade manufacturing solutions and provides small molecule APIs, advanced intermediates and starting materials. Its APIs commercial product line includes Aripiprazole, Articaine HCl, Atomoxetine HCl, Baclofen, Benserazide, Betahistine DiHCl and others. Its pipeline products include Apixaban, Acotiamide, Dexlansoprazole, Edoxaban, Erdosteine, and others.